Invictus Private Wealth LLC Sells 58 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Invictus Private Wealth LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.1% in the third quarter, according to its most recent filing with the SEC. The fund owned 463 shares of the healthcare conglomerate’s stock after selling 58 shares during the quarter. Invictus Private Wealth LLC’s holdings in UnitedHealth Group were worth $271,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at approximately $27,000. Macroview Investment Management LLC boosted its position in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the last quarter. Delos Wealth Advisors LLC raised its holdings in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the period. Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group during the 2nd quarter valued at $31,000. Finally, Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $566.96 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The company has a market cap of $523.54 billion, a PE ratio of 36.94, a P/E/G ratio of 1.64 and a beta of 0.58. The business has a 50-day simple moving average of $580.96 and a two-hundred day simple moving average of $543.36. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter last year, the company earned $6.56 earnings per share. The company’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on UNH. UBS Group decreased their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Barclays decreased their price target on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. KeyCorp initiated coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. Bank of America reduced their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Morgan Stanley reduced their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.